Rinderpest eradication: Lessons for measles eradication?

Current Opinion in Virology

Volumn 2, Issue 3, 2012, Pages 330-334

  De Swart, Rik L ^a   Duprex, W Paul ^b   Osterhaus, Albert D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

AFRICA; ASIA; CALF (BOVINE); CANINE DISTEMPER; CANINE DISTEMPER MORBILLIVIRUS; CATTLE PLAGUE VIRUS; CHILDHOOD DISEASE; DOLPHIN; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; EVOLUTION; FATALITY; FEASIBILITY STUDY; FOLLOW UP; GOAT; HEALTH CARE PLANNING; HUMAN; IMMUNITY; INFECTION CONTROL; KENYA; MAMMAL; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MORTALITY; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NONHUMAN; PHOCINE DISTEMPER; PHYLOGENY; PORPOISE; PRIORITY JOURNAL; REVIEW; RINDERPEST; RISK REDUCTION; SHEEP; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS CELL INTERACTION;

ANIMALS; CATTLE; DISEASE ERADICATION; HUMANS; MEASLES; MEASLES VIRUS; RINDERPEST; RINDERPEST VIRUS; UNITED NATIONS; WORLD HEALTH;

EID: 84862899605     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.02.010     Document Type: Review

References (52)

1. Henderson DA: The eradication of smallpox - an overview of the past, present, and future. Vaccine 2012 doi: 10.1016/ j.vaccine.2011.06.080.
2. Hinman A: Eradication of vaccine-preventable diseases. Annu Rev Public Health 1999, 20:211-229.
3. Dowdle WR, Cochi SL: The principles and feasibility of disease eradication. Vaccine 2012 doi: 10.1016/j.vaccine.2011.04.006.
4. Henderson RH: The World Health Organization's plan of action for global eradication of poliomyelitis by the year 2000. Ann N Y Acad Sci 1989, 569:69-85.
5. Cochi SL, Linkins RW: The final phase of polio eradication: new vaccines and complex choices. J Infect Dis 2012, 205:169-171. Useful update on the current status of the global polio eradication initiative.
6. Normile D: Rinderpest. Driven to extinction. Science 2008, 319:1606-1609. Easily accessible review of the different aspects of rinderpest eradication.
7. Normile D: Rinderpest, deadly for cattle, joins smallpox as a vanquished disease. Science 2010, 330:435.
8. Walsh J: War on cattle disease divides the troops. Science 1987, 237:1289-1291.
9. Roeder PL: Rinderpest: the end of cattle plague. Prev Vet Med 2011, 102:98-106. Very complete review of the different aspects of rinderpest eradication.
10. Rima BK, Wishaupt RGA, Welsh MJ, Earle JAP: The evolution of morbilliviruses: a comparison of nucleocapsid gene sequences including a porpoise morbillivirus. Vet Microbiol 1995, 44:127-134.
11. Barrett T: Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet Microbiol 1999, 69:3-13.
12. Visser IKG, Van Bressem MF, Barrett T, Osterhaus ADME: Morbillivirus infections in aquatic mammals. Vet Res 1993, 24:169-178.
13. Griffin DE: Measles virus. In Fields Virology, edn 5. Edited by Knipe DM, Howley PM.Philadelphia: Lippincott Williams & Wilkins; 2007:1551-1585.
14. Beineke A, Puff C, Seehusen F, Baumgartner W: Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 2009, 127:1-18.
15. Furuse Y, Suzuki A, Oshitani H: Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries. Virol J 2010, 7:52.
16. Visser IKG, Kumarev VP, Örvell C, De Vries P, Broeders HWJ, Van de Bildt MWG, Groen J, Teppema JS, Burger MC, UytdeHaag FGCM, Osterhaus ADME: Comparison of two morbilliviruses isolated from seals during outbreaks of distemper in North West Europe and Siberia. Arch Virol 1990, 111:149-164. (Pubitemid 20289366)
17. Harder TC, Kenter M, Appel MJG, Roelke-Parker ME, Barrett T, Osterhaus ADME: Phylogenetic evidence of canine distemper virus in Serengeti's lions. Vaccine 1995, 13:521-523.
18. Harder TC, Osterhaus ADME: Canine distemper virus - a morbillivirus in search of new hosts? Trends Microbiol 1997, 5:120-124. (Pubitemid 27139473)
19. Kennedy S, Kuiken T, Jepson PD, Deaville R, Forsyth M, Barrett T, Van de Bildt MWG, Osterhaus ADME, Eybatov T, Duck C et al.: Mass die-Off of Caspian seals caused by canine distemper virus. Emerg Infect Dis 2000, 6:637-639. (Pubitemid 32110507)
20. Qiu W, Zheng Y, Zhang S, Fan Q, Liu H, Zhang F, Wang W, Liao G, Hu R: Canine distemper outbreak in rhesus monkeys, China. Emerg Infect Dis 2011, 17:1541-1543.
21. Baron MD, Parida S, Oura CA: Peste des petits ruminants: a suitable candidate for eradication? Vet Rec 2011, 169:16-21. Good review of the interactions between RPV and PPRV.
22. Roeder PL: The animal story. BMJ 2005, 331:1262-1264.
23. Hopkins DR, Hinman AR, Koplan JP, Lane JM: The case for global measles eradication. Lancet 1982, 320:1396-1398. (Pubitemid 12119279)
24. Henderson DA: Global measles eradication. Lancet 1982, 320:208.
25. De Quadros CA: Can measles be eradicated globally? Bull World Health Organ 2004, 82:134-138.
26. WHO: Global reductions in measles mortality 2000-2008 and the risk of measles resurgence. Wkly Epidemiol Rec 2009, 84:509-516.
27. Moss WJ, Strebel P: Biological feasibility of measles eradication. J Infect Dis 2011, 204(Suppl. 1):S47-S53.
28. Bellini WJ, Rota PA: Biological feasibility of measles eradication. Virus Res 2011, 162:72-79.
29. Lievano FA, Papania MJ, Helfand RF, Harpaz R, Walls L, Katz RS, Williams I, Villamarzo YS, Rota PA, Bellini WJ: Lack of evidence of measles virus shedding in people with inapparent measles virus infections. J Infect Dis 2004, 189(Suppl. 1):165-170.
30. Featherstone DA, Rota PA, Icenogle J, Mulders MN, Jee Y, Ahmed H, de Filippis AM, Ramamurty N, Gavrilin E, Byabamazima C et al.: Expansion of the global measles and rubella laboratory network 2005-09. J Infect Dis 2011, 204(Suppl. 1):S491-S498.
31. Plowright W: The duration of immunity in cattle following inoculation of rinderpest cell culture vaccine. J Hyg (Lond) 1984, 92:285-296.
32. Mariner JC, House JA, Mebus CA, Sollod A, Stem C: Production of a thermostable VERO cell-adapted rinderpest vaccine. J Tissue Cult Methods 1991, 13:253-256.
33. De Vries RD, Stittelaar KJ, Osterhaus ADME, De Swart RL: Measles vaccination: new strategies and formulations. Expert Rev Vaccines 2008, 7:1215-1223.
34. Poland GA, Jacobson RM: The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines? Vaccine 2012, 30:103-104.
35. Omer SB, Hiremath GS, Halsey NA: Respiratory administration of measles vaccine. Lancet 2010, 375:706-708.
36. Wong-Chew RM, Garcia-Leon ML, Espinosa-Torres TB, Hernandez-Perez B, Cardiel-Marmolejo LE, Beeler JA, Audet S, Santos-Preciado JI: Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old mexican children given the same dose subcutaneously. J Infect Dis 2011, 204:426-432.
37. LiCalsi C, Maniaci MJ, Christensen T, Phillips E, Ward GH, Witham C: A powder formulation of measles vaccine for aerosol delivery. Vaccine 2001, 19:2629-2636.
38. Lin WH, Griffin DE, Rota PA, Papania M, Cape SP, Bennett D, Quinn B, Sievers RE, Shermer C, Powell K et al.: Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci USA 2011, 108:2987-2992.
39. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, Hubschen JM, Siqueira M, Beirnes J, Ahmed H et al.: Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis 2011, 204(Suppl. 1):S514-S523.
40. Caceres SB: Opinion: lessons learned from the eradication of rinderpest. Anim Health Res Rev 2011, 12:131-132.
41. Horzinek MC: Rinderpest: the second viral disease eradicated. Vet Microbiol 2011, 149:295-297.
42. Tollefson J: Seven billion and counting. Nature 2011, 478:300.
43. FAO: The State of Food and Agriculture: Livestock in the Balance. Rome: Electronic Publishing Policy and Support Branch, Communication Division, FAO; 2009.
44. Essbauer S, Pfeffer M, Meyer H: Zoonotic poxviruses. Vet Microbiol 2010, 140:229-236.
45. Reynolds MG, Damon IK: Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol 2012 doi: 10.1016/j.tim.2011.12.001. Review of outbreaks of human monkeypox in the Democratic Republic of the Congo, and their potential relation to cessation of smallpox vaccination.
46. Osterhaus ADME: Catastrophes after crossing species barriers. Philos Trans R Soc Lond B 2001, 356:791-793.
47. Stittelaar KJ, De Swart RL, Osterhaus ADME: Vaccination against measles: a neverending story. Expert Rev Vaccines 2002, 1:151-159. (Pubitemid 36686865)
48. Morens DM, Holmes EC, Davis AS, Taubenberger JK: Global rinderpest eradication: lessons learned and why humans should celebrate too. J Infect Dis 2011, 204:502-505. Review of rinderpest eradication, with emphasis on the necessity of surveillance for other morbilliviruses crossing the species barrier to humans.
49. Sanders R, Dabbagh A, Featherstone D: Risk analysis for measles reintroduction after global certification of eradication. J Infect Dis 2011, 204(Suppl. 1):S71-S77.
50. Billeter MA, Naim HY, Udem SA: Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr Top Microbiol Immunol 2009, 329:129-162.
51. Liniger M, Zuniga A, Morin TN, Combardiere B, Marty R, Wiegand M, Ilter O, Knuchel M, Naim HY: Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine 2009, 27:3299-3305.
52. Brandler S, Ruffie C, Najburg V, Frenkiel MP, Bedouelle H, Despres P, Tangy F: Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses. Vaccine 2010, 28:6730-6739.